Page 14 - HIV/AIDS Guidelines

HHS Panel on Antiretroviral Guidelines for Adults and
Adolescents Financial Disclosure (Last updated October 14, 2011; last

reviewed October 14, 2011)

Panel
Name Company Relationship
Status*
Paul Sax M Abbott • Consultant
Bristol-Myers Squibb • Advisory Board
Gilead • Advisory Board, Research Support
GlaxoSmithKline/ViiV • Consultant, Research Support
Janssen Therapeutics • Advisory Board, Research Support
(formerly Tibotec Therapeutics)
Merck • Advisory Board, Research Support
Serono • Advisory Board

Kimberly Struble M None N/A
Mark Sulkowski M Abbott • Advisory Board, Research Support
Biolex • Consultant
Boehringer Ingelheim • Advisory Board, Research Support
Bristol-Myers Squibb • Advisory Board, Research Support
Gilead • Advisory Board, Research Support
GlaxoSmithKline • Advisory Board
Janssen Therapeutics • Advisory Board, Research Support
(formerly Tibotec Therapeutics)
Merck • Advisory Board, Research Support
Pfizer • Study Steering Committee
Roche • Advisory Board, Research Support
Teva • Consultant
Vertex • Advisory Board, Research Support
Jeff Taylor M BioNor Immuno • Advisory Board, Travel Support
Boehringer Ingelheim • Advisory Board
GlaxoSmithKline Biologicals • DSMB

Zelalem Temesgen M Gilead • Advisory Board, Educational Program Support
Janssen Therapeutics • Research Support
(formerly Tibotec Therapeutics)
Merck • Advisory Board
Pfizer • Educational Program Support
ViiV • Advisory Board

Nelson Vergel M Boehringer Ingelheim • Speakers’ Bureau
(ended February 2011)
David A. Wohl M Abbott • Advisory Board
Argos • DSMB Member
BMS • Advisory Board
Gilead • Advisory Board
GlaxoSmithKline • Research Support
Janssen Therapeutics • Advisory Board
(formerly Tibotec Therapeutics)
Merck • Research Support
* C=co-chair; ES=executive secretary; M=member
DSMB = Data Safety Monitoring Board; N/A = not applicable
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents xii

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.